Clinical Research Program
The DHIVM Clinical Research Program is under the direction of Ralph Liporace, MD and coordinated by Carmella Ramnes, CCRP. Nadine Silver, RN and Cynthia Morvillo, RN are the clinical study research nurses.
The goal of the DHIVM Clinical Research Program is to provide quality state-of -the-art clinical care for those affected by HIV/AIDS. The Division has been involved in clinical research activities since May 1989 when the first AIDS-related malignancy trial patient was enrolled at AMC. The program also participated in clinical trials that led to the FDA approval of ddC (HIVID) and ddI (Videx). Since 1989, patients have participated in over 75 clinical trials covering the range of HIV/AIDS care including: antiretroviral combination therapy, viral load analysis, treatment, prophylaxis, and natural history of opportunistic infections, and complex Phase I studies of new treatments for HIV-related malignancies.
In previous years, the Research program has particpated in key clinical trials which led to the FDA approval of drugs in all four classes of anti-HIV medications. Novel medications, which represent new classes of anti-viral therapy are currently under study at AMC. According to Ralph Liporace, MD, Clinical Director of Clinical Research, "these drugs represent the most exciting and efficacious antiviral medications yet developed to fight this pandemic."
Currently, a number of HIV treatment studies are open for enrollment at our site. These studies are open to those HIV-infected individual who meet study-defined criteria. If you are interested in considering any of these trials, please call 518-262-6330.
